Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Different stem cells are key for hair growth and health, and understanding their regulation could help treat hair loss.

Autoimmune diseases can change hair texture, but treatment can restore it.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Thyroid disorders, especially autoimmune ones, are very common in the studied group.

Menopause can cause oral health issues like dry mouth and burning sensations.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Alcoholic extract of Eclipta alba may help treat allergies and is safe at high doses.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Treating gum disease and stress may help improve alopecia.